Sihwan Kim, Changmin Park, Gwanghyeon Jeon, Seohee Kim, Jong Hyo Kim
{"title":"Automated Audit and Self-Correction Algorithm for Seg-Hallucination Using MeshCNN-Based On-Demand Generative AI.","authors":"Sihwan Kim, Changmin Park, Gwanghyeon Jeon, Seohee Kim, Jong Hyo Kim","doi":"10.3390/bioengineering12010081","DOIUrl":null,"url":null,"abstract":"<p><p>Recent advancements in deep learning have significantly improved medical image segmentation. However, the generalization performance and potential risks of data-driven models remain insufficiently validated. Specifically, unrealistic segmentation predictions deviating from actual anatomical structures, known as a Seg-Hallucination, often occur in deep learning-based models. The Seg-Hallucinations can result in erroneous quantitative analyses and distort critical imaging biomarker information, yet effective audits or corrections to address these issues are rare. Therefore, we propose an automated Seg-Hallucination surveillance and correction (ASHSC) algorithm utilizing only 3D organ mask information derived from CT images without reliance on the ground truth. Two publicly available datasets were used in developing the ASHSC algorithm: 280 CT scans from the TotalSegmentator dataset for training and 274 CT scans from the Cancer Imaging Archive (TCIA) dataset for performance evaluation. The ASHSC algorithm utilizes a two-stage on-demand strategy with mesh-based convolutional neural networks and generative artificial intelligence. The segmentation quality level (SQ-level)-based surveillance stage was evaluated using the area under the receiver operating curve, sensitivity, specificity, and positive predictive value. The on-demand correction performance of the algorithm was assessed using similarity metrics: volumetric Dice score, volume error percentage, average surface distance, and Hausdorff distance. Average performance of the surveillance stage resulted in an AUROC of 0.94 ± 0.01, sensitivity of 0.82 ± 0.03, specificity of 0.90 ± 0.01, and PPV of 0.92 ± 0.01 for test dataset. After the on-demand refinement of the correction stage, all the four similarity metrics were improved compared to a single use of the AI-segmentation model. This study not only enhances the efficiency and reliability of handling the Seg-Hallucination but also eliminates the reliance on ground truth. The ASHSC algorithm offers intuitive 3D guidance for uncertainty regions, while maintaining manageable computational complexity. The SQ-level-based on-demand correction strategy adaptively minimizes uncertainties inherent in deep-learning-based organ masks and advances automated auditing and correction methodologies.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 1","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11763196/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12010081","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Recent advancements in deep learning have significantly improved medical image segmentation. However, the generalization performance and potential risks of data-driven models remain insufficiently validated. Specifically, unrealistic segmentation predictions deviating from actual anatomical structures, known as a Seg-Hallucination, often occur in deep learning-based models. The Seg-Hallucinations can result in erroneous quantitative analyses and distort critical imaging biomarker information, yet effective audits or corrections to address these issues are rare. Therefore, we propose an automated Seg-Hallucination surveillance and correction (ASHSC) algorithm utilizing only 3D organ mask information derived from CT images without reliance on the ground truth. Two publicly available datasets were used in developing the ASHSC algorithm: 280 CT scans from the TotalSegmentator dataset for training and 274 CT scans from the Cancer Imaging Archive (TCIA) dataset for performance evaluation. The ASHSC algorithm utilizes a two-stage on-demand strategy with mesh-based convolutional neural networks and generative artificial intelligence. The segmentation quality level (SQ-level)-based surveillance stage was evaluated using the area under the receiver operating curve, sensitivity, specificity, and positive predictive value. The on-demand correction performance of the algorithm was assessed using similarity metrics: volumetric Dice score, volume error percentage, average surface distance, and Hausdorff distance. Average performance of the surveillance stage resulted in an AUROC of 0.94 ± 0.01, sensitivity of 0.82 ± 0.03, specificity of 0.90 ± 0.01, and PPV of 0.92 ± 0.01 for test dataset. After the on-demand refinement of the correction stage, all the four similarity metrics were improved compared to a single use of the AI-segmentation model. This study not only enhances the efficiency and reliability of handling the Seg-Hallucination but also eliminates the reliance on ground truth. The ASHSC algorithm offers intuitive 3D guidance for uncertainty regions, while maintaining manageable computational complexity. The SQ-level-based on-demand correction strategy adaptively minimizes uncertainties inherent in deep-learning-based organ masks and advances automated auditing and correction methodologies.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering